We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). Show more
FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a...
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or...
BOTHELL, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) provides an update on the clinical development of its oral first-in-class...
BOTHELL, Wash., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the achievement of first-patient-in for the Phase 2a human...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.075 | 5.06756756757 | 1.48 | 1.5999 | 1.48 | 4719 | 1.52966523 | CS |
4 | 0.055 | 3.66666666667 | 1.5 | 1.67 | 1.35 | 13994 | 1.5117034 | CS |
12 | -0.035 | -2.20125786164 | 1.59 | 1.74 | 1.325 | 13735 | 1.49231403 | CS |
26 | -0.095 | -5.75757575758 | 1.65 | 1.99 | 1.325 | 16118 | 1.63011034 | CS |
52 | -0.895 | -36.5306122449 | 2.45 | 3.285 | 1.325 | 23040 | 2.18737972 | CS |
156 | -13.805 | -89.8763020833 | 15.36 | 41.52 | 1.325 | 1832123 | 19.15909115 | CS |
260 | -30.485 | -95.1466916355 | 32.04 | 49.2 | 1.325 | 2024409 | 18.89362689 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions